Global Total Number of 10% Top-Cited Scientific Publications in Drug Discovery by Country

In 2024, China dominates the global landscape of top-cited scientific publications in drug discovery, significantly outpacing its closest competitors, including the United States, Italy, and Egypt. China and Saudi Arabia have witnessed substantial growth, whereas the United States and other European nations have experienced declines or minor changes over recent years. Countries like Egypt, Saudi Arabia, and surprisingly Ukraine have shown remarkable increases, indicating growing research efforts or improved international collaboration in drug discovery research. Conversely, nations such as Japan, the United Kingdom, and Brazil experienced minor contractions.

Future trends to watch include the continued rise of countries like China and Saudi Arabia, potentially fueled by increased investments in scientific research and international collaborations. Emerging players like Egypt and Ukraine may further enhance their contributions to high-impact drug discovery research, driven by strategic policy shifts and increased global integration in science. Monitoring geopolitical influences and innovation-driven economies in biotechnology and pharmaceuticals will be crucial for understanding these dynamics.